NSD1 mediates antagonism between SWI/SNF and polycomb complexes and is required for transcriptional activation upon EZH2 inhibitionYiannis Drosos, Charles W.M. Roberts, Margaret E. Larsen et al.|Molecular Cell|2022Cited by 53
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumorSanthosh A. Upadhyaya, Amar Gajjar, Anne Bendel et al.|Neuro-Oncology|2022Cited by 29